Doctors may inadvertently be creating a new generation of illegal, recreational drug users by prescribing anti-anxiety or sleep medications to teenagers, say University of Michigan researchers.
Teenagers prescribed anxiety or sleep medications are up to 12 times more likely to abuse those drugs than those who have never received a prescription, often by obtaining additional pills from friends or family members, the findings showed.
Nearly nine percent of the 2,745 adolescent study participants had received a prescription for anxiety or sleep medications during their lifetime, and more than three percent received at least one prescription during the three-year study period.
"I recognise the importance of these medications in treating anxiety and sleep problems. However, the number of adolescents prescribed these medications and the number misusing them is disturbing for several reasons," said Carol Boyd, the study's first author and professor of women's studies.
Anxiety and sleep medications can be addictive or even fatal when mixed with narcotics or alcohol.
"What happened to Australian actor Heath Ledger could happen to any teenager who is misusing these medications, particularly if the teenager uses alcohol in combination with these drugs," Boyd added.
Ledger died from combined drug intoxication involving prescription drugs in 2008.
Examples of anti-anxiety medications include Klonopin, Xanax and Ativan; sleep medications include Ambien, Restoril and Lunesta.
"These are controlled substances partly because of their potential for abuse and it is a felony to share them," Boyd said.
The researchers recommend better education for parents and adolescents prescribed these medications, monitoring refills and making it standard practice to provide teenagers with a substance use assessment before prescribing these drugs.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
